Founder of UK based investment firm that recently created Oxford Cannabinoid Technologies.
Neil began his career at Morgan Stanley in London and before founding Kingsley worked at J. Rothschild Capital Management, leading several illiquid transactions for Lord Rothschild's family office and RIT Capital Partners plc.
Neil sources and manages a variety of illiquid investments for KCP. He is a Director of portfolio company Forma Holdings and Oxford Cannabinoid Technologies, a member of the investment committee at Albright Capital Management, and a board member of emerging markets design firm MASS Group.
Neil is British and enjoys playing the piano. He holds a degree in Biological Sciences from the University of Oxford (a President of the Oxford Union) and an MBA from the Harvard Business School (a Fulbright Scholar).